Endpoints News
Lilly invests in Oura Read in browser
Endpoints News
Thursday, 16 July 2026
Thank you for reading, dupa dupackia!
basic
UPGRADE
Manufacturing Day 2026
A year into the tariff era, the biopharma industry has stopped bracing for impact — however manufacturing and supply chain leaders are still rewriting their plans on the fly. We’re bringing together the experts tracking what R&D logistics looks like today. Join us — find out what’s next.
What health system execs are talking about
Earlier this week, I swung by the American Hospital Association’s Leadership Summit in downtown Denver.
When I wasn’t giving out ice cream recommendations, I was trying to get a sense of what hospital leaders are focused on. Of course, we talked about some of the tech changes happening at hospitals, reimbursement headwinds from legislative changes and 340B payment challenges. But one topic that came up in my conversations almost unprompted was how health systems’ use of AI will impact jobs. 
“AI can incredibly transform the care that we deliver without harming our employees and our care team members,” Dominica Tallarico, chief operating officer at Minnesota-based, 12-hospital Allina Health, told me. “I think we've got to look at upskilling or different-skilling our workforce.” She said she hasn’t seen a decrease in full-time employees at her organization. 
Marjorie Bessel, chief clinical officer at the Arizona-headquartered, 33-hospital Banner Health, told me she expects the transition will be more focused on staff being assigned different tasks, rather than job cuts themselves. “We’re just going to be able to redeploy them to other needs that we have across our organization, and hopefully, other needs that would be more impactful to the patient experiential component, as well as to our overall business,” she said. 
On the one hand, this makes sense to me: Healthcare jobs have been one of the consistently growing parts of the US economy. I tend to hear more about staffing shortages at facilities than I do layoffs.
But at the same time, there’s a lot of general anxiety around AI taking jobs. Healthcare, a place that’s readily accepting AI, isn’t exempt.
I’ve been waiting to see whether we’ll see layoffs hit healthcare attributed to AI, in the same way has happened at some tech companies. But so far, I haven’t picked up on any notable trends. Are you seeing something different play out at your organization? Let’s talk. 
- Lydia
Here’s what’s new
Eli Lilly invests in Oura to support patients on GLP-1 drugs
Eli Lil­ly on Wednes­day made an eq­ui­ty in­vest­ment in wear­able ring start­up Oura as the drug­mak­er looks for ways to help pa­tients tak­ing its GLP-1 med­ica­tions.
Deal activity heats up
71 Q2 was a busy quarter for digital health acquisitions, tallying 71 deals. That’s the highest it’s been since the third quarter of 2021, Rock Health reported in its H1 report this week.
This week in health Тech
Swedish full body scan company Neko Health has raised $700 million as it plans to open its first clinics in the US. It plans to open clinics starting in New York, this year, entering an increasingly crowded and popular market for longevity and preventive health services. The Series C was co-led by Lightspeed Venture Partners and O.G. Venture Partners.
The FTC settled its insulin lawsuit with CVS Caremark, following a similar settlement with Cigna's Express Scripts earlier this year. In both settlements, the pharmacy benefit managers agreed to count prescriptions paid for via TrumpRx toward deductibles. That's typically a big issue facing cash-pay pricing.
Robin Shah, co-founder and CEO of cancer care unicorn Thyme Care, is stepping down to become its executive chairman. Shah will be succeeded as CEO by Brad Diephuis, Thyme’s current president and COO.
AlleyCorp raised a new $335 million fund. The New York-based venture firm is a big backer of healthcare startups including Thyme and Maven.
Endpoints News
2029 Becker Drive; Lawrence, Kansas 66047 USA Privacy and deletion: help@endpointsnews.com
web twitter linkedin
Worldwide made. Thanks for reading.
Unsubscribe preferences
Unsubscribe from all newsletters
FT Specialist Logo A service from the Financial Times